Antibodies from Ebola survivor protect mice and ferrets against related viruses


Read about how our NIAID-funded study could lead to broad, versatile treatments for many different Ebolaviruses.

Researchers funded in part by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), have studied the blood of an Ebola survivor, searching for human antibodies that might effectively treat not only people infected with Ebola virus, but those infected with related viruses as well. Now the researchers have identified two such antibodies that hold promise as Ebola treatments.